A5048089029- Transcranial Magnetic Stimulation Studies
- Neurological disorders and treatments
- Liver Disease Diagnosis and Treatment
- Cardiovascular Health and Risk Factors
- Stroke Rehabilitation and Recovery
- Porphyrin Metabolism and Disorders
- Hereditary Neurological Disorders
- Neurological diseases and metabolism
- Health, Environment, Cognitive Aging
- Attention Deficit Hyperactivity Disorder
- Pain Management and Treatment
- Genetic Neurodegenerative Diseases
- Health Systems, Economic Evaluations, Quality of Life
- Acute Ischemic Stroke Management
- Birth, Development, and Health
- Neural and Behavioral Psychology Studies
University of Shanghai for Science and Technology
2025
First Affiliated Hospital of Fujian Medical University
2016-2025
Fujian Medical University
2016-2025
Hangzhou First People's Hospital
2023-2024
First Affiliated Hospital Zhejiang University
2022
The benefits of ideal cardiovascular-health metrics (ICVHMs) in patients with renal insufficiency remain unclear. This study aimed to investigate ICVHM associations prognosis a population. trial enrolled 29,682 participants from the US National Health and Nutrition Examination Survey (NHANES), 2007-2018, mortality follow-up through December 31, 2019. Participants were divided into three groups based on estimated glomerular filtration rates. Cardiovascular health was assessed using new...
Pantothenate kinase-associated neurodegeneration (PKAN) is a rare autosomal recessive neurodegenerative disorder resulting from pantothenate kinase 2 (PANK2) gene mutations. It clinically characterized by early onset of extrapyramidal symptoms, with or without pigmentary retinopathy, optic atrophy and acanthocytosis. The specific radiographic appearance PKAN the eye-of-the-tiger sign. However, there are few studies regarding patients Chinese Han ancestry. In present study, 20-year-old female...
<h3>Importance</h3> Promotion of clinician adherence to stroke guidelines can improve outcomes. <h3>Objective</h3> To investigate the outcomes a multilevel system program on for treatment patients with acute ischemic (AIS). <h3>Design, Setting, and Participants</h3> This quality improvement study used prospective interrupted time series (ITS) difference-in-difference (DID) design, from August 1, 2018, January 31, 2020, divided into preprogram term short long postprogram terms; each had 6...
Liver transplant is an unreplaceable method for benign end-stage liver disease. The risk evaluation the waiting list recipients and post-transplant survival could provide practical indication organ allocation. In recent years, there are two major kinds of scores. first kind scores based on model disease(MELD) score,including SOFT/P-SOFT score,UCLA-FRS score BAR score. other system concept acute-on-chronic failure,including CLIF-C-ACLF score,TAM score,AARC-ACLF COSSH-ACLF ACLF have been shown...